| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96f502867dd470369ec522f89871e553 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-0321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-0389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-0325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-0346 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-0303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-72 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483 |
| filingDate |
2001-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4d56de5ab24b7de000494601ad1d58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b9511608d98609c4eef53275c54573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_478421f037c34d680cc461f47533a867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d35fc1563dbc2b006f82355f689c8cd0 |
| publicationDate |
2003-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1303746-A1 |
| titleOfInvention |
Analysis method and cuvette therefor |
| abstract |
The present invention concerns a method for hemoglobin determination which comprises the steps of introducing a sample of undiluted whole blood by capillary action into a disposable microcuvette having at least one cavity for receiving the sample. The cavity includes a dry essentially non-hygroscopic hemolysing agent, which is dissolved by the blood, hemolyses the red blood cells and releases the haemoglobin contained in the blood cells. A first absorption measurement at a wavelength range 490-520 nm is then performed directly on the sample in the microcuvette, and a second absorption measurement is performed to compensate for background interference. |
| priorityDate |
2000-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |